Trial Profile
Follow-up Study to Evaluate the Sustained Efficacy and Safety for the Patients With Adipoplus Injected in Phase II Clinical Trials(ANTG-ASC-202)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Fistula
- Focus Therapeutic Use
- Sponsors Anterogen
- 21 Nov 2016 Status changed from active, no longer recruiting to completed.
- 04 Nov 2014 New trial record